Total Credits: .75 including .75 AMA PRA Category 1 Credit(s)™, .75 AOA Category 1-A Credit(s)
*** Please note this webinar will also be found as part of the 3.25-Credit program Common Diseases & Disorders & Viruses. If you have already completed Common Diseases & Disorders & Viruses, you will not want to choose this program. If you want to learn more about Common Diseases & Disorders & Viruses, choose “Media Types” above and select “Classroom.” ***
Dr. Burns will provide an update on the state of the field, including an overview of how Alzheimer's disease changes the brain and how the disease is currently recognized and diagnosed. Dr. Burns will provide an update on the current attempts to develop new drugs to treat and how researchers are using lifestyle factors (such as physical exercise and diet) to develop prevention strategies. Additionally, Dr. Burns will discuss medical innovations that may make it possible to detect Alzheimer's disease in adults before memory problems begin.
• Discuss the early recognition and diagnosis of Alzheimer’s disease.
• Discuss the most up-to-date available treatments for Alzheimer's disease and the treatment impact on the disorder.
• Discuss major research advances that may lead to improved diagnostic, treatment, and prevention efforts for Alzheimer’s disease.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of .75 AOA Category 1-A Credits and will report CME and specialty credits commensurate with the extent of the physician's participation.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of .75 AMA PRA Category 1 Creditsä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and Kansas City University College of Osteopathic Medicine. MAOPS is accredited by the ACCME to provide continuing medical education for physicians.
None of the planners for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Grievance Policy for AOA Credit:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
Jeffrey M. Burns, MD, MS is the Edward H. Hashinger Professor of Neurology and the Co-Director of the University of Kansas Alzheimer’s Disease Center (KU ADRC). Dr. Burns also directs the Clinical and Translational Science Unit, the Department of Neurology’s Memory Care Clinic, and leads the KU ADRC’s Clinical Core and AD Trial Team, which is a site for the ADCS and ATRI national trial networks. Dr. Burns started the AD clinical research program at KU in 2004 to stimulate and support AD and aging research locally while pursuing research investigating how various lifestyle factors influence brain aging and AD. The program has grown into a vibrant research and training environment for AD and brain aging research. Dr. Burns has been continuously funded as a PI by the NIH since 2005 for work focused on how various lifestyle factors influence brain aging and AD progression.
Jeffrey Burns, MD, MS, discloses he receives research support for NIH, is a site investigator for trails from Novaritis et al, and a consultant for renw research.
Dr. Burns can be reached at firstname.lastname@example.org.